The VIX Crashes Out, For Now, on Hope For Peace and Cheaper Oil

Photo of Austin Smith
By Austin Smith Published

Quick Read

  • Arm (ARM) surged 13% after unveiling its AGI CPU for agentic AI workloads, projecting $25B in total revenue and $9 per share in annual earnings within five years with $15B tied to the new chip, while Intel (INTC) rose 3% and AMD (AMD) climbed over 1% as investors viewed the cycle as broadly positive for CPU demand. Sarepta Therapeutics (SRPT) gained on plans to file for full FDA approval of two Duchenne muscular dystrophy therapies, Amondys 45 and Vyondys 53, converting accelerated approvals into permanent regulatory standing. Robin Energy Ltd. (RBNE) surged nearly 92% on 181M shares as a micro-cap tanker company with just $14.3M market cap, though the move reflects speculative trading rather than fundamental shifts given 94% revenue concentration in a single pool.

  • A reported 15-point U.S. peace plan transmitted to Iran through Pakistan and a sharp 5% drop in oil prices to $87 WTI sent investors back into equities, with the S&P 500 up 0.6%, Nasdaq up 0.7%, and Russell 2000 leading with a 1.2% gain as cheaper energy eases inflation pressure on consumer-facing companies.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The VIX Crashes Out, For Now, on Hope For Peace and Cheaper Oil

© monsitj / iStock via Getty Images

The fear gauge pulled back on Wednesday. The CBOE Volatility Index, better known as the VIX, is trading near 25.6 this morning, a drop of roughly 5% from Tuesday’s close of 26.95, as geopolitical optimism and a sharp pullback in oil prices sent investors back into equities. The major indices are all pushing higher, with the S&P 500 up 0.6%, the Dow up 0.7%, the Nasdaq up 0.7%, and the Russell 2000 leading with a 1.2% gain in early trading.

Peace Hopes and Cheaper Oil Are Doing the Heavy Lifting

The session’s dominant catalyst is a reported 15-point U.S. peace plan presented to Iran to halt the Middle East conflict, transmitted through intermediary Pakistan. The proposal signals a push by the Trump administration to de-escalate a war that has rattled global supply chains and energy markets. Iran has pushed back on characterizations of direct talks, leaving some uncertainty, but the market is responding to the direction of travel.

Oil is the most direct transmission mechanism. West Texas Intermediate crude fell to around $87 per barrel and Brent crude dropped below $95, with WTI down more than 5% on the day. Oil had surged to a 52-week high of $98.48 just last week on March 13, stoking fresh inflation concerns. A pullback of this magnitude eases pressure on the Fed and gives consumer-facing companies breathing room on costs. Lower energy prices act as a direct stimulus to household budgets, which is why small-caps in the Russell 2000 are outpacing large-cap peers today: smaller domestic companies are more sensitive to consumer spending conditions.

Three Stocks Moving the Needle

Arm Holdings (NASDAQ:ARM | ARM Price Prediction) is the standout mover, surging over 13% after unveiling its first in-house data center chip: the AGI CPU, designed for agentic AI workloads. CEO Rene Haas laid out a roadmap projecting $25 billion in total revenue and $9 per share in annual earnings within five years, with roughly $15 billion of that tied directly to the new chip. Meta Platforms is the lead launch partner. Arm has historically earned royalties on chips others design using its architecture. Building its own silicon changes the revenue model entirely and positions the company to capture a larger share of the AI infrastructure buildout. The announcement also lifted Intel (NASDAQ:INTC) shares by 3% and Advanced Micro Devices (NASDAQ:AMD) by more than 1%, as investors read the agentic AI chip cycle as broadly positive for CPU demand across the sector.

Sarepta Therapeutics (NASDAQ:SRPT) is climbing after announcing plans to file supplemental new drug applications with the FDA seeking full approval for two Duchenne muscular dystrophy therapies, Amondys 45 and Vyondys 53. The filings, targeted for April, would convert accelerated approvals into full regulatory standing, strengthening the commercial durability of both drugs. For a company navigating a difficult stretch following prior FDA scrutiny of its gene therapy program, the regulatory progress reads as a credibility rebuild.

Robin Energy Ltd. (NASDAQ:RBNE) is the session’s most explosive mover, surging nearly 92% on volume of 181 million shares. The small-cap shipping company, which operates tanker vessels and recently expanded into LPG carriers, has a market cap of just $14.3 million. Moves of this magnitude in micro-cap names often reflect speculative trading rather than fundamental shifts. The company carries meaningful risks including 94% revenue concentration in a single tanker pool arrangement and repeated equity dilution through share offerings.

What the VIX Level Is Actually Telling You

At around 25.6, the VIX remains in the elevated uncertainty zone. The 20 to 30 range signals meaningful investor anxiety, well above the 12-month average of 19 and the December 2025 low of 13.47. The current reading sits at the 93rd percentile of the past year, meaning markets have been calmer than this on 93% of trading days over the last 12 months. The VIX had already climbed 41% over the prior month before today, so one session of optimism does not erase the underlying uncertainty around trade policy, Middle East conflict resolution, and the Fed’s rate path.

The Iran peace talks remain the key variable. Oil prices are the clearest real-time indicator of how that story is developing: if WTI holds below $90, that sustains the inflation relief narrative, while a move back toward $100 would likely push the VIX higher again.

Photo of Austin Smith
About the Author Austin Smith →

Austin Smith is a financial publisher with over two decades of experience in the markets. He spent over a decade at The Motley Fool as a senior editor for Fool.com, portfolio advisor for Millionacres, and launched new brands in the personal finance and real estate investing space.

His work has been featured on Fool.com, NPR, CNBC, USA Today, Yahoo Finance, MSN, AOL, Marketwatch, and many other publications. Today he writes for 24/7 Wall St and covers equities, REITs, and ETFs for readers. He is as an advisor to private companies, and co-hosts The AI Investor Podcast.

When not looking for investment opportunities, he can be found skiing, running, or playing soccer with his children. Learn more about me here.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618